News | Advanced Visualization | January 20, 2016

High-resolution peripheral quantitative CT reveals patients with type 2 diabetes have structural defects that could be treated to prevent future fractures

University of Southampton, HR-pQCT, type 2 diabetes, bone fracture risk

Three dimensional structure of a human tibia obtained by high-resolution-peripheral quantitative computer tomography (HR-pQCT) scanning and showing compact bone (periphery) and trabecular bone (center). (Credit NASA and Bone Imaging Laboratory, University of Calgary, Canada)


January 20, 2016 — A University of Southampton study using high-resolution imaging to create a “virtual bone biopsy” has shed new light on why people with type 2 diabetes are at risk of bone fractures.

Researchers from the Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, used high-resolution peripheral quantitative computed tomography (HRpQCT) to assess bone structure and strength at a microstructural level in living patients.

The images showed that individuals with type 2 diabetes have structural defects within their bones, which could weaken them and go some way to explaining the greater rates of fracture found in older men and women with the disease.

Lead researcher Mark Edwards, Ph.D., clinical lecturer at the University of Southampton, commented: “This is a very interesting discovery using a very novel technique. We’ve known for some time that people with type 2 diabetes are at risk of fracture but have not been able to fully explain why.

“This new imaging technique has been able to identify that the cortical component of bone – the outer rim of the bone – tends to exhibit greater porosity in those with type 2 diabetes compared to those without. We can now see where there is a specific deficit within the bone, which may help clinicians to develop appropriate therapies to prevent future fractures.”

The study, which is published in Calcified Tissue International, scanned a group of 177 men and 155 women, who were part of the Hertfordshire Cohort Study. Their average age was around 76 years at the time of the study.

Prof. Cyrus Cooper, director of the MRC Lifecourse Epidemiology Unit, University of Southampton, commented: “This study highlights an important link between diabetes and osteoporosis, and identifies a selective deficit in skeletal development, which leads to excess fracture risk in this increasingly frequent disorder. It also demonstrates that environmental influences during critical periods of early development might lead to several common non-communicable disorders in western populations.”

For more information: www.mrc.soton.ac.uk


Related Content

News | X-Ray

April 29, 2026 — Results from a new study* presented at the American Roentgen Ray Society’s (ARRS) 2026 annual meeting ...

Time April 29, 2026
arrow
News | Imaging Software Development

April 28, 2026 — Avatar Medical has been granted FDA 510(k) clearance for Avatar Medical Vision, its software platform ...

Time April 28, 2026
arrow
News | Cardiac Imaging

April 28, 2026 — Abbott has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its next ...

Time April 28, 2026
arrow
News | Contrast Agents

April 23, 2026 — On April 23, GE HealthCare announced the first patient has been dosed in the international, multi ...

Time April 23, 2026
arrow
News | FDA

April 16, 2026 — Royal Philips has received U.S. Food and Drug Administration 510(k) clearance for the Philips Spectral ...

Time April 20, 2026
arrow
News | Radiology Imaging

April 7, 2026 — Onvida Health and Siemens Healthineers have entered a 10-year Value Partnership¹ designed to bring the ...

Time April 09, 2026
arrow
News | Radiology Business

March 31, 2026 — Radon Medical Imaging, a medical imaging equipment maintenance and repair services company, has has ...

Time March 31, 2026
arrow
News | Radiology Imaging

March 26, 2026 — GE HealthCare has announced a renewed research collaboration with Stanford Medicine Department of ...

Time March 30, 2026
arrow
News | Cardiac Imaging

March 28, 2026 — When Ashley Perlow felt a sharp pain shoot across her chest and into both wrists, she didn't think it ...

Time March 30, 2026
arrow
News | FDA

March 24, 2026 — MARS Bioimaging, a New Zealand–headquartered medical device company, has received U.S. Food and Drug ...

Time March 25, 2026
arrow
Subscribe Now